Correction to: An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology

Ítems similars

• An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology
  per: Sani, Noraisyah Mohd, et al.
  Publicat: (2020)
• An evaluation of the Caribbean regulatory system centralized assessment process for medicines submitted 2017–2018 using the OpERA methodology
  per: Liberti, Lawrence, et al.
  Publicat: (2020)
• Antibacterial activity of selected Malaysian honey
  per: Zainol, Mohd Izwan, et al.
  Publicat: (2013)
• To what degree are review outcomes aligned for new active substances (NASs) between the European Medicines Agency and the US Food and Drug Administration? A comparison based on publicly available information for NASs initially approved in the time period 2014 to 2016
  per: Kühler, Thomas Christian, et al.
  Publicat: (2019)
• To what degree are review outcomes aligned for new active substances (NASs) between the European Medicines Agency and the US Food and Drug Administration? A comparison based on publicly available information for NASs initially approved in the time period 2014 to 2016
  per: Thomas Christian Kühler, et al.
  Publicat: (2019-11-01)